Effect of baseline Alberta Stroke Program Early CT Score on safety and efficacy of intra-arterial treatment: a subgroup analysis of a randomised phase 3 trial (MR CLEAN)

AJ Yoo; Olvert Berkhemer; Puck Fransen; LA van den Berg; D Beumer; Hester Lingsma; WJ Schonewille; MES Sprengers; R van den Berg; MAA Walderveen; LFM Beenen; MJH Wermer; GJLA Nijeholt; J Boiten; SFM Jenniskens; JCJ Bot; AMM Boers; HA Marquering; YBWEM Roos; RJ van Oostenbrugge; Diederik Dippel; Aad van der Lugt; WH Zwam; CBLM Majoie

Effect of baseline Alberta Stroke Program Early CT Score on safety and efficacy of intra-arterial treatment: a subgroup analysis of a randomised phase 3 trial (MR CLEAN)

AJ Yoo, Olvert Berkhemer, Puck Fransen, LA van den Berg, D Beumer, Hester Lingsma, WJ Schonewille, MES Sprengers, R van den Berg, MAA Walderveen, LFM Beenen, MJH Wermer, GJLA Nijeholt, J Boiten, SFM Jenniskens, JCJ Bot, AMM Boers, HA Marquering, YBWEM Roos, RJ van OostenbruggeDiederik Dippel, Aad van der Lugt, WH Zwam, CBLM Majoie

Research output: Contribution to journal › Article › Academic › peer-review

104 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	685-694
Number of pages	10
Journal	Lancet Neurology
Volume	15
Issue number	7
Publication status	Published - 2016

Research programs

EMC COEUR-09
EMC NIHES-03-30-01

Cite this

Yoo, AJ., Berkhemer, O., Fransen, P., van den Berg, LA., Beumer, D., Lingsma, H., Schonewille, WJ., Sprengers, MES., van den Berg, R., Walderveen, MAA., Beenen, LFM., Wermer, MJH., Nijeholt, GJLA., Boiten, J., Jenniskens, SFM., Bot, JCJ., Boers, AMM., Marquering, HA., Roos, YBWEM., ... Majoie, CBLM. (2016). Effect of baseline Alberta Stroke Program Early CT Score on safety and efficacy of intra-arterial treatment: a subgroup analysis of a randomised phase 3 trial (MR CLEAN). Lancet Neurology, 15(7), 685-694.

@article{bfe2516a10f94a6ca83612bec9f85847,

title = "Effect of baseline Alberta Stroke Program Early CT Score on safety and efficacy of intra-arterial treatment: a subgroup analysis of a randomised phase 3 trial (MR CLEAN)",

author = "AJ Yoo and Olvert Berkhemer and Puck Fransen and {van den Berg}, LA and D Beumer and Hester Lingsma and WJ Schonewille and MES Sprengers and {van den Berg}, R and MAA Walderveen and LFM Beenen and MJH Wermer and GJLA Nijeholt and J Boiten and SFM Jenniskens and JCJ Bot and AMM Boers and HA Marquering and YBWEM Roos and {van Oostenbrugge}, RJ and Diederik Dippel and {van der Lugt}, Aad and WH Zwam and CBLM Majoie",

year = "2016",

language = "Undefined/Unknown",

volume = "15",

pages = "685--694",

journal = "Lancet Neurology",

issn = "1474-4422",

publisher = "Elsevier Ltd.",

number = "7",

}

Yoo, AJ, Berkhemer, O, Fransen, P, van den Berg, LA, Beumer, D, Lingsma, H, Schonewille, WJ, Sprengers, MES, van den Berg, R, Walderveen, MAA, Beenen, LFM, Wermer, MJH, Nijeholt, GJLA, Boiten, J, Jenniskens, SFM, Bot, JCJ, Boers, AMM, Marquering, HA, Roos, YBWEM, van Oostenbrugge, RJ, Dippel, D , van der Lugt, A, Zwam, WH & Majoie, CBLM 2016, 'Effect of baseline Alberta Stroke Program Early CT Score on safety and efficacy of intra-arterial treatment: a subgroup analysis of a randomised phase 3 trial (MR CLEAN)', Lancet Neurology, vol. 15, no. 7, pp. 685-694.

TY - JOUR

T1 - Effect of baseline Alberta Stroke Program Early CT Score on safety and efficacy of intra-arterial treatment: a subgroup analysis of a randomised phase 3 trial (MR CLEAN)

AU - Yoo, AJ

AU - Berkhemer, Olvert

AU - Fransen, Puck

AU - van den Berg, LA

AU - Beumer, D

AU - Lingsma, Hester

AU - Schonewille, WJ

AU - Sprengers, MES

AU - van den Berg, R

AU - Walderveen, MAA

AU - Beenen, LFM

AU - Wermer, MJH

AU - Nijeholt, GJLA

AU - Boiten, J

AU - Jenniskens, SFM

AU - Bot, JCJ

AU - Boers, AMM

AU - Marquering, HA

AU - Roos, YBWEM

AU - van Oostenbrugge, RJ

AU - Dippel, Diederik

AU - van der Lugt, Aad

AU - Zwam, WH

AU - Majoie, CBLM

PY - 2016

Y1 - 2016

M3 - Article

SN - 1474-4422

VL - 15

SP - 685

EP - 694

JO - Lancet Neurology

JF - Lancet Neurology

IS - 7

ER -